Moreover, in people with severe COVID-19 the infection reveals a diminished antiviral response marked by the downregulation of antiviral genes such as OAS1, SAMD9L and IFIT2, and suppression of antiviral immune response pathways48. This evidence concerns the gene OAS1 and COVID-19.